Yutaka Kawakami

Keio University - Division of Cellular Signaling Institute for Advanced Medical Research

Tokyo

Japan

SCHOLARLY PAPERS

1

DOWNLOADS

23

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

VEGF Receptors Peptide Vaccine in Neurofibromatosis Type 2: A Single-Arm, Open-Label, Phase 1/2 Trial

Number of pages: 72 Posted: 02 Mar 2019
Ryota Tamura, Masato Fujioka, Yukina Morimoto, Kentaro Ohara, Kenzo Kosugi, Yumiko Oishi, Mizuto Sato, Ryo Ueda, Hirokazu Fujiwara, Shinobu Noji, Naoki Oishi, Kaoru Ogawa, Yutaka Kawakami, Takayuki Ohira, Kazunari Yoshida and Masahiro Toda
Keio University - Department of Neurosurgery, Keio University - Department of Otorhinolaryngology, Head and Neck Surgery, Keio University - Department of Neurosurgery, Keio University - Department of Pathology, Keio University - Department of Neurosurgery, Keio University - Department of Neurosurgery, Keio University - Department of Neurosurgery, Keio University - Department of Neurosurgery, Keio University - Department of Radiology, Keio University - Division of Cellular Signaling Institute for Advanced Medical Research, Keio University - Department of Otorhinolaryngology, Head and Neck Surgery, Keio University - Department of Otorhinolaryngology, Head and Neck Surgery, Keio University - Division of Cellular Signaling Institute for Advanced Medical Research, Keio University - Department of Neurosurgery, Keio University - Department of Neurosurgery and Keio University - Department of Neurosurgery
Downloads 23 (538,049)

Abstract:

Loading...

VEGF receptor; peptide vaccine; NF2; schwannoma: meningioma